RecruitingNot ApplicableNCT06642610

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis

CGM Dynamic Index (CDI) for Predicting Prediabetes in People With Cystic Fibrosis

Sponsor

Indiana University

Enrollment

70 participants

Start Date

Jun 15, 2025

Study Type

INTERVENTIONAL

Conditions

Prediabetes Cystic Fibrosis-related Diabetes Cystic Fibrosis (CF)

Summary

The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.

Eligibility

Min Age: 12 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called CGM Dynamic Index (CDI) for people with cystic fibrosis (cf), cystic fibrosis-related diabetes, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.